These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16905646)

  • 21. Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older.
    Gregg EW; Gu Q; Williams D; de Rekeneire N; Cheng YJ; Geiss L; Engelgau M
    Diabetes Res Clin Pract; 2007 Sep; 77(3):485-8. PubMed ID: 17306411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and risk factors for neuropathy in a Canadian First Nation community.
    Bruce SG; Young TK
    Diabetes Care; 2008 Sep; 31(9):1837-41. PubMed ID: 18509208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral Neuropathy and Vision and Hearing Impairment in US Adults With and Without Diabetes.
    Hicks CW; Wang D; Lin FR; Reed N; Windham BG; Selvin E
    Am J Epidemiol; 2023 Feb; 192(2):237-245. PubMed ID: 36345076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes, vestibular dysfunction, and falls: analyses from the National Health and Nutrition Examination Survey.
    Agrawal Y; Carey JP; Della Santina CC; Schubert MC; Minor LB
    Otol Neurotol; 2010 Dec; 31(9):1445-50. PubMed ID: 20856157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demographic characteristics of individuals with diabetes mellitus and peripheral neuropathy.
    Tata S; Morewitz S; Tan KH; Clark J
    J Am Podiatr Med Assoc; 2013; 103(5):355-60. PubMed ID: 24072362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evaluation of peripheral neuropathy in youth with type 1 diabetes.
    Moser JT; Langdon DR; Finkel RS; Ratcliffe SJ; Foley LR; Andrews-Rearson ML; Murphy KM; Lipman TH
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e3-6. PubMed ID: 23391743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements.
    McGill M; Molyneaux L; Spencer R; Heng LF; Yue DK
    Diabetes Care; 1999 Apr; 22(4):598-602. PubMed ID: 10189538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Peripheral Neuropathy with Erectile Dysfunction in US Men.
    Hicks CW; Wang D; Windham BG; Selvin E
    Am J Med; 2021 Feb; 134(2):282-284. PubMed ID: 32805230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral Neuropathy and the Insensate Foot: More Than Diabetes.
    Sibbald RG; Ayello EA
    Adv Skin Wound Care; 2019 Apr; 32(4):149. PubMed ID: 30889015
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor?
    Tseng CH
    CMAJ; 2006 Jan; 174(3):319-23. PubMed ID: 16446472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.
    Tesfaye S; Stevens LK; Stephenson JM; Fuller JH; Plater M; Ionescu-Tirgoviste C; Nuber A; Pozza G; Ward JD
    Diabetologia; 1996 Nov; 39(11):1377-84. PubMed ID: 8933008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study.
    Davis TM; Yeap BB; Davis WA; Bruce DG
    Diabetologia; 2008 Apr; 51(4):562-6. PubMed ID: 18193189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.
    Aubert CE; Michel PL; Gillery P; Jaisson S; Fonfrede M; Morel F; Hartemann A; Bourron O
    Diabetes Metab Res Rev; 2014 Nov; 30(8):679-85. PubMed ID: 24449227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Underdiagnosis of peripheral neuropathy in type 2 diabetes.
    Herman WH; Kennedy L
    Diabetes Care; 2005 Jun; 28(6):1480-1. PubMed ID: 15920071
    [No Abstract]   [Full Text] [Related]  

  • 35. Mobility limitation among persons aged > or =40 years with and without diagnosed diabetes and lower extremity disease--United States, 1999-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(46):1183-6. PubMed ID: 16304555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy.
    Candrilli SD; Davis KL; Kan HJ; Lucero MA; Rousculp MD
    J Diabetes Complications; 2007; 21(5):306-14. PubMed ID: 17825755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population.
    Harris M; Eastman R; Cowie C
    Diabetes Care; 1993 Nov; 16(11):1446-52. PubMed ID: 8299433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between interleg systolic blood pressure difference and apparent peripheral neuropathy in US adults with diabetes: a cross-sectional study.
    Lin X; Liu Z; Weng H; Liu X; Liu S; Li J
    J Health Popul Nutr; 2023 Nov; 42(1):131. PubMed ID: 38001545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and risk factors of diabetic peripheral neuropathy in Type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China.
    Li L; Chen J; Wang J; Cai D
    Prim Care Diabetes; 2015 Jun; 9(3):191-5. PubMed ID: 25163987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.
    Olaleye D; Perkins BA; Bril V
    Diabetes Res Clin Pract; 2001 Nov; 54(2):115-28. PubMed ID: 11640995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.